Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Upgraded Ultrasound System Features Tissue Contrast Enhancement

By HospiMedica International staff writers
Posted on 23 Sep 2010
A new ultrasound system is designed for routine examinations in breast, cardiac, ob/gyn, and vascular imaging, as well as deep abdominal penetration for challenging cases. More...
Powerful imaging enhancements include dynamic tissue contrast enhancement (TCE) technology, a new algorithm that provides advanced speckle reduction in combination with enhanced contrast resolution.

Siemens Healthcare (Erlangen, Germany) has extended the performance of its Acuson S2000 ultrasound system with a reworking of features and functionality. With user workflow under the spotlight, the new S2000 2.0 offers excellent imaging capabilities promoting improved patient throughput and diagnostic confidence.

Queen Elizabeth Hospital Birmingham, part of University Hospitals Birmingham NHS [National Health Service] Foundation Trust, is the first site to receive the new upgraded S2000. The system innovation is further bolstered with the strengthening of Siemens' U.K. sales and application teams. This will enable the roll out of a nationwide upgrade to existing installed customers and drive momentum of the powerful performance benefits to wider ultrasound communities.

"The S2000 is already acclaimed as the first commercially available implementation of acoustic radiation force impulse [ARFI] technology, but this new generation system is also ideal for routine diagnostic imaging,” stated Andrew Pattison, NW Europe head of ultrasound at Siemens Healthcare. "A new innovation in our solution range at the same time as team expansion means that we're in great shape to support our customers' clinical and training needs.”

When combined with advanced SieClear spatial compounding, the technology provides greater flexibility and diagnostic confidence. HD Zoom is another additional feature that increases the line density in the region of interest while magnifying the image resulting in greater detail resolution.

Furthermore, the new S2000 introduces Siemens' second-generation implementation of ARFI for even greater sensitivity and accuracy. With the addition of the 9L4 transducer, Virtual Touch HD technology can now be used for small parts, breast and thyroid as well as abdominal imaging. The eSie Touch elasticity imaging enhancements, a new strain ratio, calculates the average ratio of strain within two user-selected regions of interest giving comparative measures for a more informed diagnosis. The addition of new color maps further increases options for viewing elastograms. Both these developments support the depth of data delivered to clinicians performing penetrating examinations.

Related Links:
Siemens Healthcare



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Hypodermic Syringe
SurTract™ Safety Syringe
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.